Tumore al fegato

Il cancro al fegato è il sesto tumore al mondo, per incidenza, e l’epatocarcinoma (HCC) rappresenta il 90% di casi di cancro al fegato. In Italia sono 13.000 i nuovi casi di tumore al fegato previsti per il 2020. 

Referenze

 

1. WHO: Globocan 2018 – Liver cancer factsheet. [Internet; cited 2019 July 24] Available from: http://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf.

2. Llovet J, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018

3. Bucci L, Garuti F, Lenzi B, et al. The evolutionary scenario of hepatocellular carcinoma in Italy: an update. Liver Int. 2017;37(2):259-270

4. Medscape. [Internet; cited 2019 July 24]. Available from: https://emedicine.medscape.com/article/369226-overview

5. Marrero K, Kulik L, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-750

6. Medline. [Internet; cited 2019 July 24]. Available from: https://medlineplus.gov/ency/article/000280.htm

7. El-Serag HB Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264–1273 e1261 (2012).

8. Global Burden of Disease Cancer, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3, 524–548 (2017).

9. Orphanet, “Prevalenza e incidenza delle malattie rare: Dati bibliografici”, I Quaderni di Orphanet Numero 2 Gennaio 2020.

10. AIOM-AIRTUM, “I numeri del cancro in Italia 2020”, Gruppo di lavoro AIOM, AIRTUM, Fondazione AIOM, PASSI

11. Bucci L, Garuti F, Lenzi B, et al. The evolutionary scenario of hepatocellular carcinoma in Italy: an update. Liver Int. 2017;37(2):259-270.

12. AIOM-AIRTUM “Linee guida: EPATOCARCINOMA” Edizione 2019. Consultabile al link: https://www.aiom.it/wp-content/uploads/2019/10/2019_LG_AIOM_Epatocarcinoma.pdf

13. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589-604

14. Heimbach JK, Kulik LM, Finn RS, et al. AASLD Guidelines for the Treatment of Hepatocellular Carcinoma.  HEPATOLOGY, 67, n. 1, 2018